Cautions regarding the fitting and interpretation of survival curves: examples from NICE single technology appraisals of drugs for cancer.
about
Difference in Restricted Mean Survival Time for Cost-Effectiveness Analysis Using Individual Patient Data Meta-Analysis: Evidence from a Case Study.Estimation of Survival Probabilities for Use in Cost-effectiveness Analyses: A Comparison of a Multi-state Modeling Survival Analysis Approach with Partitioned Survival and Markov Decision-Analytic ModelingCost-effectiveness Analysis in R Using a Multi-state Modeling Survival Analysis Framework: A TutorialSurvival analysis for economic evaluations alongside clinical trials--extrapolation with patient-level data: inconsistencies, limitations, and a practical guide.Mean overall survival gain with aflibercept plus FOLFIRI vs placebo plus FOLFIRI in patients with previously treated metastatic colorectal cancer.
P2860
Cautions regarding the fitting and interpretation of survival curves: examples from NICE single technology appraisals of drugs for cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Cautions regarding the fitting ...... ppraisals of drugs for cancer.
@en
Cautions regarding the fitting ...... ppraisals of drugs for cancer.
@nl
type
label
Cautions regarding the fitting ...... ppraisals of drugs for cancer.
@en
Cautions regarding the fitting ...... ppraisals of drugs for cancer.
@nl
prefLabel
Cautions regarding the fitting ...... ppraisals of drugs for cancer.
@en
Cautions regarding the fitting ...... ppraisals of drugs for cancer.
@nl
P2093
P2860
P1433
P1476
Cautions regarding the fitting ...... ppraisals of drugs for cancer.
@en
P2093
Chris Hyde
David Moore
Martin Connock
P2860
P304
P356
10.2165/11585940-000000000-00000
P577
2011-10-01T00:00:00Z
P6179
1002466604